International Menopause Society report highlights under-recognition and under-treatment of chronic pain in midlife women
AI-generated summary
The International Menopause Society released a report estimating that about half of all middle-aged women experience chronic pain, which is defined as pain lasting more than three months or recurring. Women are up to 70 per cent more likely than men to experience chronic pain, with symptoms often appearing in midlife due to fluctuating hormones, menopause-related biological shifts, lack of sleep, and lifestyle changes.
Women are up to 70 per cent more likely to experience chronic pain than men, according to a recent report from the international Menopause Society (IMS).
Chronic pain is pain that lasts more than three months, or keeps recurring.
In women, these pain symptoms often appear in midlife, likely due to factors such as fluctuating hormones, menopause-related biological shifts, lack of sleep and lifestyle changes.
The IMS report estimates about half of all middle-aged women experience chronic pain, describing the condition as "often under-recognised, underdiagnosed and inadequately treated".
Rossella Nappi, IMS president and obstetrician and gynaecologist at the University of Pavia in Italy, says the report aims to empower women and health workers to talk about the condition.
"Chronic pain in midlife is a very important subject and highly neglected," she says.
"Sometimes the pain becomes widespread and it's present in every day of their life."
So what do we know about chronic pain in women and what can people do to minimise the severity of their symptoms?
Why is chronic pain more common in women?
We don't know for sure.
Adelaide University senior lecturer in pain science Jane Chalmers says this is one of the "hardest questions to answer" in her field.
"Trying to understand why certain people or certain groups are more vulnerable to others is often multi-factorial and very layered," she says.
"And that's because we can't separate a human's psychology and sociology from their biology."
Women often experience multiple, overlapping chronic pain syndromes, such as fibromyalgia and chronic pelvic pain.
While not everyone feels pain in the same way, some research suggests women may be more likely than men to experience central sensitisation, making the brain more likely to produce pain signals.
And then there are social factors.
Chronic Pain Australia chair Nicollette Ellis, who is also a pharmacist specialising in chronic pain, says women often manage the majority of caregiving responsibilities, which may add to stress levels.
The relationship between stress and chronic pain is complex, but stress may worsen pain intensity for some people.
Why do these changes happen in midlife?
Hormones play a role.
During menopause, which marks the end of a woman's reproductive years, the body produces much lower amounts of oestrogen and progesterone.
Lower levels of oestrogen can lead to joint pain, stiffness and weakening of muscles.
But these hormone levels can fluctuate day-to-day, explains Royal Australian College of General Practitioners menopause health subgroup chair Sharon Vasey.
This fluctuation can lead to migraines, she says.
But it's not all about hormones. Professor Nappi says lifestyle factors also play a key role in how we age.
"If we do not exercise properly, if we don't eat adequately and if we are not active very much in our life, pain will be an issue," she says.
"If we have menopausal symptoms, such as sleep disturbances, for example, or mood changes, this will affect the experience of the pain."
What type of pain do women report?
The IMS report focuses on three common symptoms: musculoskeletal pain, migraine and pelvic pain.
According to the report, nearly three in four women experience joint or muscle pain during perimenopause.
But figures from Chronic Pain Australia's 2026 National Pain Report paint a more complex picture.
The group surveyed more than 6,000 Australians, finding women experience an average of 4.6 different types of chronic pain, such as migraines, back, pelvic, joint or nerve pain.
With so many women reporting multiple symptoms, Ms Ellis says it's important not to treat types of pain in a "silo", but to consider the whole body and how different systems interact.
What can women do about it?
For women approaching midlife, Dr Vasey says it's important to get enough sleep, stay active and eat a healthy diet.
She says the first step for people experiencing pain symptoms is to speak to their GP.
"There's lots of things that can be done, women don't have to put up with chronic pain," she says.
Dr Vasey, who is also a practising GP, says menopausal hormone therapy can help ease the severity of some symptoms for some women, but medication isn't the only option.
It can also be helpful to see an allied health worker, such as a physiotherapist.
As many people with chronic pain experienced a delayed diagnosis, Ms Ellis says it is important health workers take pain symptoms seriously.
"The earlier we can treat [chronic pain] the better the outcomes," she says.
And a broader level, Monash University professor of occupational rheumatology Karen Walker-Bone says more needs to be done to support women approaching midlife.
This means making sure women have the financial stability to retire when they want, and to ensure emotional household labour is shared in an equitable way.
Social media influencers are promoting unapproved peptides to hundreds of thousands of followers, fuelling a black market worth up to $4 billion. Australian health data shows emergency department visits linked to these substances rose from 5 per month in July 2025 to nearly 220 in September 2026, while a coroner linked actor Richard Norton's death to peptide injection. The ABC traced supply to unregulated labs in Guangzhou and Shenzhen, China.
ABC investigation reveals influencers like Josh Sawyer promoting unapproved injectable peptides to hundreds of thousands of followers, while Australian health agencies report surging harm including hospitalisations and a death. The black market is worth up to $4 billion, with supply largely traced to unregulated Chinese laboratories.
NT Health has banned smart glasses at all clinical sites after a medical observer posted confidential images and videos of 12 pregnant patients to Instagram. Chief executive Susan Bowden announced the ban in an internal email, while NT Health Minister Steve Edgington paused the medical observership program and referred the breach to the NT Information Commissioner and NT Police.
Calvary Health Care will stop IVF, elective abortions, voluntary assisted dying, and gender reassignment procedures if it acquires Newcastle and Hunter Valley Private hospitals later this month, pending regulatory approvals from the ACCC and NSW Health. The Catholic provider's planned takeover of 14 hospitals follows Healthscope's collapse, sparking concerns from health workers and community advocates about impacts on women's reproductive health in regional New South Wales.
Australia's TGA has approved four strengths of Wegovy tablets (1.5mg–25mg), the first GLP-1 medicine in tablet form for weight management in Australia. The daily oral semaglutide offers similar weight loss to injections but requires strict daily adherence and is not PBS-subsidised, with out-of-pocket costs likely similar to injections at A$250–$450 monthly.
A woman in her 30s with underlying health conditions died at Royal Darwin Hospital after contracting leptospirosis while hunting near a billabong in a remote Top End community. NT Health confirmed 11 cases in 2026, up from six in 2025, and urges anyone with symptoms to seek urgent medical attention.